Drug discovery Archives

The FDA has issued revised draft guidance for early treatment of Alzheimer’s disease with drugmakers told to focus on medicines that are likely to predict a clinical benefit.

FDA issues revised drug guidelines for early Alzheimer’s disease

HQ Team March 12, 2024: The FDA has issued revised draft guidance for early treatment of Alzheimer’s disease with drugmakers told to focus.

by HealthQuill
March 12, 2024
0 Comments

Cardiometabolic diseases are a group of common but often preventable conditions including heart attack, stroke, diabetes, insulin resistance and non-alcoholic fatty liver disease.

Drugs Health Pharma

Novo Nordisk, Valo Health sign $2.7 billion pact for drug discovery

HQ Team September 25, 2023: Novo Nordisk and Valo Health, Inc., have signed a $2.7 billion pact to discover and develop novel treatments.

by HealthQuill
September 25, 2023
0 Comments

Nvidia has invested $50 million in a clinical-stage biotechnology company, Recursion, to speed up the development of artificial intelligence models for drug recovery and may later license them, according to a statement.

Drugs Health Pharma

Nvidia invests $50 million in Recursion to hasten AI drug recovery

HQ Team July 12, 2023: Nvidia has invested $50 million in a clinical-stage biotechnology company, Recursion, to speed up the development of artificial.

by HealthQuill
July 13, 2023
0 Comments

US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.

Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

by HealthQuill
April 17, 2023
0 Comments

BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.

Drugs Medical Pharma

BioNTech, OncoC4 in pact to develop drug for solid tumours

BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.